In a recent study involving an early-onset Parkinson's disease model (PARK20), where PERK is consistently activated, inhibition of PERK phosphorylation by GSK2606414 has been found to have positive effects on ER stress and mitochondrial dysfunction [140]. This evidence concerns the gene EIF2AK3 and Parkinson disease.